Australia, N.Z. Stocks: Alchemia, Cochlear, Fortescue, Newcrest

Australia’s S&P/ASX 200 Index (AS51) rose 0.4 percent to 4,514.80 at the 4:10 p.m. close of trading in Sydney. New Zealand’s NZX 50 Index (NZSE50FG) fell 0.2 percent to 3,424.35 at the 5 p.m. close in Wellington.

The following were among the most active shares in the market today. Stock symbols are in parentheses after company names.


Gold producers: Gold futures for August delivery gained 0.9 percent to settle at a record $1,562.30 an ounce on the Comex in New York yesterday.

Newcrest Mining Ltd. (NCM) , Australia’s biggest gold producer, rose 0.7 percent to A$38.96. Rival OceanaGold Corp. (OGC) gained 4.5 percent to A$2.78.

Retailers: Australian consumer confidence fell by the most since Lehman Brothers Holdings Inc. collapsed in 2008 as concern intensified about the European debt crisis.

David Jones Ltd. (DJS) , Australia’s second-biggest department store chain, fell 1.8 percent to A$3.91. Harvey Norman Holdings Ltd. (HVN) , the nation’s largest furniture and electrical retailer, declined 2.4 percent to A$2.41.

Alchemia Ltd. (ACL) jumped 30 percent to 80 Australian cents. The Australian developer of the first generic form of GlaxoSmithKline Plc’s blood thinner Arixtra said the U.S. Food and Drug Administration approved the product for sale in the U.S.

Cochlear Ltd. (COH) climbed 2.5 percent to A$70.84. The maker of the world’s best-selling hearing implant had its stock rating raised to “hold” from “sell” at Citigroup Inc.

Fortescue Metals Group Ltd. (FMG) climbed 1.6 percent to A$6.38. The iron-ore producer is mulling a Hong Kong or Shanghai listing, the Australian newspaper reported on its website yesterday, citing an interview with Chief Executive Andrew Forrest.

New Zealand:

Ryman Healthcare Ltd. (RYM) , New Zealand’s largest publicly traded retirement village manager, fell 4 percent to NZ$2.65. Tainui Group Holdings Ltd. sold its 4.5 percent holding in Ryman to help cut debt levels, website reported.

To contact the reporter on this story: Shani Raja in Sydney at

To contact the editors responsible for this story: Nick Gentle at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.